2007
DOI: 10.1016/j.jpsychires.2006.03.006
|View full text |Cite
|
Sign up to set email alerts
|

Brain metabolic changes associated with predispotion to onset of major depressive disorder and adjustment disorder in cancer patients –A preliminary PET study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
33
0
1

Year Published

2007
2007
2018
2018

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 56 publications
(39 citation statements)
references
References 36 publications
5
33
0
1
Order By: Relevance
“…Creatine's elevation in 1 H-MRS has been attributed to altered metabolism (50). Our elevated creatine finding is consistent with altered metabolism, as suggested by earlier studies that found both decreased (4,5,(51)(52)(53) and increased (7,54) basal ganglia/caudate blood flow and glucose metabolism in major depression. Indeed, 31 P-MRS, capable of quantifying nucleoside triphosphates, has further implicated basal ganglia metabolism in major depression (55,56).…”
Section: Creatinesupporting
confidence: 92%
See 1 more Smart Citation
“…Creatine's elevation in 1 H-MRS has been attributed to altered metabolism (50). Our elevated creatine finding is consistent with altered metabolism, as suggested by earlier studies that found both decreased (4,5,(51)(52)(53) and increased (7,54) basal ganglia/caudate blood flow and glucose metabolism in major depression. Indeed, 31 P-MRS, capable of quantifying nucleoside triphosphates, has further implicated basal ganglia metabolism in major depression (55,56).…”
Section: Creatinesupporting
confidence: 92%
“…In adults with major depression, change in left caudate regional cerebral blood flow correlated with the emergence of depressive symptoms after interruption of paroxetine treatment (65). In cancer patients, increased left caudate glucose metabolism at baseline was associated with depressive symptoms 2 years later compared with patients who did not develop depression (54). Taken together, these findings emphasize the potential role of metabolic probes for early identification of major depressive disorder, perhaps even before the onset of clinical symptoms.…”
Section: Lateralization Of Caudate Metabolic Abnormalities In Major Dmentioning
confidence: 89%
“…To date, there is a paucity of studies on depressive mood-related brain lesions in CKD patients who do not yet require dialysis. Many investigators have suggested that the depressive mood-related brain lesions in patients with major depression are located in the prefrontal cortex, superior temporal gyrus, cingulate gyrus, amygdala, thalamus, striatum, and so on [14][15][16]. In several reports, diverse, heterogeneous, and confl icting results, showing both increases and discordance in the locations of reduced rCBF, have also been reported [17][18][19][20].…”
Section: Discussionmentioning
confidence: 99%
“…For example, relative to controls depressed MDD and BD subjects show metabolic activity that appears reduced in the sgACC (Figure 8) (Drevets et al, 1997a(Drevets et al, , 2002aLiotti et al, 2002;Ketter et al, 2001;Kegeles et al, 2003;Kruger et al, 2003;Pizzagalli et al, 2004). These metabolic reductions may predate the onset of clinical symptoms as (Kumano et al, 2006) found that cancer patients who went on to develop depression had lower baseline metabolic rates of the sgACC compared with cancer controls who did not become depressed. However, other studies reported increased metabolic activity in the sgACC in primary (Wu et al, 1999;Mayberg et al, 2000Mayberg et al, , 2005 (Inagaki et al, 2007).…”
Section: Neurophysiological Imaging In Major Depressive and Bipolar Dmentioning
confidence: 98%